Skip to main navigation menu Skip to main content Skip to site footer
Brazilian Journal of Clinical Medicine and Review

Health Review

Vol. 4 No. 1 (2026): January/December - 2026

Relationship Between COVID-19 and Cardiovascular Disease in Critically Ill Patients: A Systematic Review of the Literature

DOI
https://doi.org/10.52600/2965-0968.bjcmr.2026.4.1.bjcmr59
Submitted
February 1, 2026
Published
2026-03-06

Abstract

Cardiovascular complications are frequently reported in patients with severe COVID-19; however, their spectrum and clinical relevance in critically ill patients have not been fully characterized. To systematically review the literature to identify the main cardiovascular complications occurring in patients with severe COVID-19 admitted to intensive care units (ICUs). A systematic search of three electronic databases was conducted from December 2019 to January 1, 2025. Observational studies including adult patients with severe COVID-19 admitted to ICUs and reporting cardiovascular complications were eligible, without language restrictions. Study selection and qualitative synthesis were performed according to predefined criteria. The primary outcomes were pre-existing cardiovascular comorbidities and cardiovascular complications occurring during ICU stay. Eight observational cohort studies met the inclusion criteria. A high prevalence of baseline cardiovascular comorbidities was consistently reported, particularly arterial hypertension, obesity, smoking history, and diabetes mellitus. The most frequently described cardiovascular complications in critically ill patients included circulatory failure, thromboembolic events, myocardial injury, cardiac arrhythmias, and cerebrovascular events. The reported frequency of these complications varied across studies. Cardiovascular complications are common among critically ill patients with COVID-19, with circulatory failure and thromboembolic and arrhythmic events being the most consistently reported. These findings highlight the need for early cardiovascular monitoring and multidisciplinary management in this population.

References

  1. World Health Organization. Coronavirus disease (COVID-19) fact sheet. Geneva: World Health Organization; 2025 Nov 27.
  2. Basu-Ray I, Almaddah NK, Vaqar S, Soos MP. Cardiac manifestations of coronavirus (COVID-19). In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.
  3. Hernández-Cárdenas CM, Choreño-Parra JA, Torruco-Sotelo C, et al. Clinical risk factors for mortality among critically ill Mexican patients with COVID-19. Front Med (Lausanne). 2021;8:699607. doi:10.3389/fmed.2021.699607.
  4. Hayek SS, Brenner SK, Azam TU, Shadid HR, Anderson E, Berlin H, et al. In-hospital cardiac arrest in critically ill patients with COVID-19: multicentre cohort study. BMJ. 2020;371:m3513. doi:10.1136/bmj.m3513.
  5. Gao P, Wu W, Tian R, Yan X, et al. Association between tachyarrhythmia and mortality in a cohort of critically ill patients with coronavirus disease 2019 (COVID-19). Ann Transl Med. 2021;9(10):883. doi:10.21037/atm-21-2282.
  6. Vijayabharathy K, Schilling J. Incidence and prognostic impact of new-onset atrial fibrillation in patients with severe COVID-19: a retrospective cohort study. J Atr Fibrillation. 2021.
  7. Wetterslev M, Jacobsen PK, Hassager C, et al. Cardiac arrhythmias in critically ill patients with coronavirus disease 2019: a retrospective population-based cohort study. Acta Anaesthesiol Scand. 2021;65:770-777.
  8. Soares Brandão J, et al. Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital. Int J Infect Dis. 2021.
  9. Ferrando C, Mellado-Artigas R, Gea A, Arruti E, et al. Características, evolución clínica y factores asociados a la mortalidad en UCI de los pacientes críticos infectados por SARS-CoV-2 en España: estudio prospectivo, de cohorte y multicéntrico. Rev Esp Anestesiol Reanim. 2020 Oct;67(8):425-437. doi:10.1016/j.redar.2020.07.003.
  10. Kunutsor SK, Laukkanen JA. Cardiovascular complications in COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):e139-e141. doi:10.1016/j.jinf.2020.05.068.
  11. Lala A, Johnson KW, Januzzi JL, Russak AJ, et al. Prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection. J Am Coll Cardiol. 2020;76(5):533-546. doi:10.1016/j.jacc.2020.06.007.
  12. Qian, H., Gao, P., Tian, R., et al. (2021). Myocardial injury on admission as a risk in critically ill COVID-19 patients: A retro-spective in-ICU study. Journal of Cardiothoracic and Vascular Anesthesia, 35(3), 846–853.
  13. Wang D, Yin Y, Hu C, Liu X, Zhang X, Zhou S, et al. Clinical course and outcome of 107 patients infected with SARS-CoV-2 discharged from two hospitals in Wuhan, China. Crit Care. 2020;24(1):188.
  14. Key insights into recent advances and challenges in COVID-19 management. Discover Public Health. 2025;22:15.